Recipharm commences new supply contract and completes purchase of facility in Spain

pharmafile | December 4, 2017 | News story | Manufacturing and Production Recipharm 

Recipharm AB announces that it has today commenced the supply of commercial products to Roche and completed the acquisition of the manufacturing facility located in Leganés, Spain.

Thomas Eldered, CEO of Recipharm commented: “We are continuing to gain momentum in the CDMO market and this latest agreement is another demonstration of this. I welcome our new colleagues in Spain and look forward to providing Roche with first-class CDMO services”. 

Contact information
Thomas Eldered, CEO, telephone: +46 8 602 52 10
Henrik Stenqvist, CFO, ir@recipharm.com, telephone: +46 8 602 52 00

This information is information that Recipharm AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 1 December 2017, at 13:00 CET. 

Related Content

Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON

Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based …

Recipharm designates Germany site as Centre of Excellence

The multi-product facility recently underwent significant renovations

handshake

Strategic alliance announced between Recipharm and Exela

Recipharm and Exela have announced that they have entered into an exclusive strategic alliance. The …

The Gateway to Local Adoption Series

Latest content